# Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/Flu

> **NCT02904304** · PHASE3 · SUSPENDED · sponsor: **Ache Laboratorios Farmaceuticos S.A.** · enrollment: 150 (estimated)

## Conditions studied

- Cold

## Interventions

- **DRUG:** Desloratadine+Phenylephrine+Ibuprofen
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02904304
- **Lead sponsor:** Ache Laboratorios Farmaceuticos S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2020-12
- **Primary completion:** 2021-07
- **Final completion:** 2021-09
- **Target enrollment:** 150 (ESTIMATED)
- **Why stopped:** the viability of the study is being analyzed
- **Last updated:** 2019-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02904304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02904304, "Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/Flu". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02904304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*